Dr Kari Johansen obtained her medical degree from the Karolinska Institute in Stockholm, where she also did her PhD (1999). Prior to joining the European Centre for Disease Prevention and Control (ECDC) in 2008, Dr Johansen worked for the Swedish Institute for Infectious Disease Control (SMI) and the Swedish National Reference group for Vaccine Preventable Diseases (REFVAC). Since 2014, she has been a member of the World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE), of which she was elected vice-chair in 2016 and has represented at the Global Advisory Committee on Vaccine Safety. Since 2018, she has led a new EU-EEA national immunisation technical advisory group (NITAG) collaboration initiative hosted by the ECDC, which was set up to share and collate evidence on the efficacy, effectiveness and safety of new and updated vaccines used in EU-EEA national immunisation programmes.
Scientist: Kari Johansen
A scientist’s opinion : Interview with Dr Kari Johansen about vaccine procedure
Dr Kari Johansen is expert in influenza and other respiratory viruses and vaccine-preventable diseases at the ECDC. She obtained her medical degree from the Karolinska Institute in Stockholm, where she also did her PhD (1999). Prior to joining the European Centre for Disease Prevention and Control (ECDC) in 2008, Dr Johansen worked for the Swedish ...
COVID-19: ensuring a safe and effective vaccine
Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) for their thoughts.
